Various stakeholders have issued recommendations regarding the use of genomics in
pediatrics. These guidelines are driven in part by concerns about psychosocial risks of …

Importance Newborn genomic sequencing (nGS) may provide health benefits throughout
the life span, but there are concerns that it could also have an unfavorable (ie, negative) …

BACKGROUND AND OBJECTIVES: There is interest in applying genomic sequencing (GS)
to newborns' clinical care. Here we explore parents' and clinicians' attitudes toward and …

Purpose Newborn genomic sequencing (nGS) has great potential to improve pediatric care.
Parental interest and concerns about genomics are relatively unexplored. Understanding …

The BabySeq Project is a study funded by the National Institutes of Health and aimed at
exploring the medical, behavioral, and economic impacts of integrating genomic sequencing …

The return of information from genomic sequencing in children, especially in early life, brings
up complex issues around parental autonomy, the child's future autonomy, the best interest …

Purpose In 2014, our institution launched a randomized controlled trial (RCT) comparing
rapid genome sequencing (GS) to standard clinical evaluations of infants with suspected …

Objective Ethical evaluation of genetic testing in children is traditionally based on balancing
clinical benefits and risks. However, this focus can be inconsistent with the general practice …

Introduction: With increasing utility and decreasing cost of genomic sequencing,
augmentation of standard newborn screening (NBS) programs with newborn genomic …

As genome‐wide sequencing (GWS; exome sequencing [ES] and whole genome
sequencing [WGS]) is implemented more frequently in the neonatal intensive care unit …